Many years ago I published on the anti-inflammatory properties of a particular fatty acid (lipid or fat) that is currently not commercialized, and only known by a handful of researchers (myself being the leading expert). I found it to potently reduce inflammation in animal models and human cells (15 studies), and to be more effective than fish oils in this regard. It is a fatty acid that has likely played a key role in evolution from dinosaurs to humans, but was lost during human industrialization. Along with “modern lifestyle” changes, deficiency of this fatty acid may contribute to chronic inflammation and it’s many associated diseases (e.g., heart disease, obesity, arthritis, gut diseases, skin diseases….). Due to a desire to truly help manage chronic inflammation and help people feel better, I am developing a company in the USA (Sciadonics) along with business partners who share this vision. The goal is to commercialize this special fatty acid for its potent anti-inflammatory properties across several channels. We have already accomplished many important milestones (e.g., milestones achieved in sourcing, processing, and intellectual property). At this juncture, I am reaching out to colleagues in my personal- or extended network to: purchase our special oil; to invest in our company (purchase equity or provide capital); and for other forms of partnering.